Oorsprong van het eerstegraads netwerk van Andreas Oeri
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 78 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Andreas Oeri via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Chief Operating Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Chief Executive Officer Human Resources Officer Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Public Communications Contact Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Chairman Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Director/Board Member Chairman Director/Board Member | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
| University of St. Gallen | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Graduate Degree Masters Business Admin Director/Board Member | |
| University of Basel | College/University | Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
Forum Mondial de L'Economie
 Forum Mondial de L'Economie Miscellaneous Commercial ServicesCommercial Services Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member Chairman Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| INSEAD | College/University | Masters Business Admin Director/Board Member Undergraduate Degree Masters Business Admin Masters Business Admin | |
| European Round Table of Industrialists | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Chief Executive Officer Director of Finance/CFO President Chief Executive Officer | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Director/Board Member Chairman Corporate Officer/Principal Corporate Officer/Principal | |
Roche Holdings, Inc.
 Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Financial Conglomerates | Director/Board Member Chief Executive Officer Director/Board Member Chairman | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Stanford University | College/University | Corporate Officer/Principal Corporate Officer/Principal Masters Business Admin Doctorate Degree | |
| NESTLÉ S.A. | Food: Major Diversified | Director/Board Member Director/Board Member Chairman Comptroller/Controller/Auditor | |
| UBS | Investment Managers | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| University of Zurich | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
Stiftung Avenir Suisse
 Stiftung Avenir Suisse Investment Trusts/Mutual FundsMiscellaneous Stiftung Avenir Suisse develops ideas for the sociopolitical and economic development of Switzerland. It comprises of companies and private individuals from all economic branches and regions of Switzerland. The company was founded in 1999 and is headquartered in Zurich, Switzerland. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Corporate Officer/Principal Director of Finance/CFO Chairman Director/Board Member | |
| NOVIMMUNE SA | Medical/Nursing Services | Chairman Chairman Director/Board Member | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
| SYNGENTA | Chemicals: Agricultural | Director of Finance/CFO Director/Board Member Treasurer | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| ALCON INC. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Equipment/Instruments | President Corporate Officer/Principal Corporate Officer/Principal | |
| BB BIOTECH AG | Financial Conglomerates | Chairman Director/Board Member Director/Board Member | |
| The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree | |
Berta Holding AG
 Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland. | Biotechnology | Chairman Director/Board Member | |
EngMab SARL
 EngMab SARL Pharmaceuticals: MajorHealth Technology EngMab SARL operates as a biotechnology company. It focuses on cancer immunotherapy and hematological malignancies and solid tumors. The company was founded by Klaus Strein in 2013 and is headquartered in Pfäffikon, Switzerland. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree Graduate Degree | |
| Institut de hautes études internationales et du développement | College/University | Corporate Officer/Principal Undergraduate Degree | |
| CLARIANT AG | Chemicals: Specialty | Chairman Director/Board Member | |
Cimeio Therapeutics AG
 Cimeio Therapeutics AG Packaged SoftwareTechnology Services Cimeio Therapeutics AG is an applied gene editing and immunotherapy company based in Basel, Switzerland. Cimeio is developing a portfolio of shielded-cell & immunotherapy pairs™ (scip) that have the potential to transform hematopoietic stem cell transplant. The Swiss company's technology platform is based on the design and expression of modified variants of naturally occurring cell surface proteins in hscs. These novel variants maintain their function but are resistant to depletion when targeted by a paired immunotherapy which has high affinity for the wild-type version of these proteins. Cimeio is the leader of the field of epitope editing and is developing a portfolio of shielded-cell & immunotherapy pairs™ (scip), novel immunotherapies which have the potential to transform treatment of hematologic diseases. The company develops state-of-the-art immunotherapies, along with paired, modified variants of naturally occurring cell surface proteins in hscs. These immunotherapies have significant therapeutic potential, which Cimeio is using to develop curative treatments for patients with hematologic malignancies, autoimmune disorders, and genetic diseases. The company was founded by Lukas Jeker and the CEO is Thomas Fuchs. | Packaged Software | Director/Board Member Director/Board Member | |
ETH Zürich Foundation
 ETH Zürich Foundation Investment Trusts/Mutual FundsMiscellaneous ETH Zürich Foundation engages in promoting teaching and research. It specializes in developing new professorships, providing scholarship's, research, teaching and infrastructure facilities. The company was founded in 2003 and is headquartered in Zurich, Switzerland. | Investment Trusts/Mutual Funds | Chairman Director/Board Member | |
| SWISS LIFE HOLDING AG | Life/Health Insurance | Chairman Chief Executive Officer | |
| MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
Okairos AG
 Okairos AG Pharmaceuticals: MajorHealth Technology Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Roche Diagnostics AG
 Roche Diagnostics AG Medical SpecialtiesHealth Technology Part of Novartis AG, Roche Diagnostics AG is a Swiss healthcare company committed to improving lives through innovative medicines and diagnostic tests. The company is based in Rotkreuz, Switzerland. Roche has been a pioneer in healthcare since its founding in 1896 and has helped millions of patients worldwide. | Medical Specialties | Director of Finance/CFO Chief Executive Officer | |
Okairos SRL
 Okairos SRL Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Okairos SRL is an Italian company that manufactures drugs. The company is based in Rome, Italy. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Chairman Director/Board Member | |
Roche Diagnostics A/S
 Roche Diagnostics A/S BiotechnologyHealth Technology Roche Diagnostics A/S provides diagnostic solutions. The company is headquartered in Hvidovre, Denmark. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| Lamkap Bio Alpha AG | Chairman Chairman | ||
| ACCELERATE DIAGNOSTICS, INC. | Medical Specialties | Chairman Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| LUFTHANSA | Airlines | Chief Executive Officer Corporate Officer/Principal | |
| TURNSTONE BIOLOGICS CORP. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer |
Statistieken
Internationaal
| Zwitserland | 27 |
| Verenigde Staten | 13 |
| Duitsland | 6 |
| Japan | 2 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 20 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 6 |
| Miscellaneous | 3 |
Operationeel
| Director/Board Member | 523 |
| Corporate Officer/Principal | 266 |
| Chairman | 187 |
| Independent Dir/Board Member | 110 |
| Chief Executive Officer | 87 |
Sterkste connecties
| Insiders | |
|---|---|
| André S. Hoffmann | 52 |
| Franz Humer | 45 |
| Bradley Bolzon | 41 |
| Peter Brabeck-Letmathe | 32 |
| Gerald Heinz Möller | 29 |
| Wolfgang Ruttenstorfer | 29 |
| Erich Hunziker | 28 |
| Paul Bulcke | 28 |
| William Burns | 27 |
| John Bell | 27 |
| Christoph Franz | 27 |
| Richard Scheller | 27 |
| Claudia Dyckerhoff | 26 |
| Peter Voser | 25 |
| Daniel Zabrowski | 23 |
- Beurs
- Insiders
- Andreas Oeri
- Bedrijfsconnecties
